Peak6 Investments LLC Alnylam Pharmaceuticals, Inc. Call Options Transaction History

Peak6 Investments LLC

$43.5 Billion
Q3 2024

Call Options

17 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	BUY	$233.81 - $287.01 $4.98 Million - $6.11 Million	21,300 Added 253.57%	29,700 $8.17 Million
Q2 2024 Aug 13, 2024	BUY	$143.31 - $247.0 $845,529 - $1.46 Million	5,900 Added 236.0%	8,400 $2.04 Million
Q1 2024 May 14, 2024	SELL	$146.51 - $198.2 $1.03 Million - $1.39 Million	-7,000 Reduced 73.68%	2,500 $373,000
Q4 2023 Feb 13, 2024	BUY	$151.41 - $196.57 $1.44 Million - $1.87 Million	9,500 New	9,500 $1.82 Million
Q2 2023 Aug 11, 2023	BUY	$185.01 - $212.05 $462,525 - $530,125	2,500 New	2,500 $474,000
Q4 2022 Feb 10, 2023	SELL	$185.53 - $241.31 $18,553 - $24,131	-100 Reduced 50.0%	100 $24,000
Q3 2022 Nov 14, 2022	BUY	$138.54 - $232.0 $13,854 - $23,200	100 Added 100.0%	200 $40,000
Q2 2022 Aug 12, 2022	SELL	$120.42 - $169.29 $469,638 - $660,231	-3,900 Reduced 97.5%	100 $15,000
Q1 2022 May 13, 2022	SELL	$127.18 - $173.91 $788,516 - $1.08 Million	-6,200 Reduced 60.78%	4,000 $653,000
Q4 2021 Feb 11, 2022	BUY	$159.56 - $209.29 $1.63 Million - $2.13 Million	10,200 New	10,200 $1.73 Million
Q3 2021 Nov 12, 2021	SELL	$169.75 - $207.73 $4.24 Million - $5.19 Million	-25,000 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$128.63 - $176.89 $2.73 Million - $3.75 Million	21,200 Added 557.89%	25,000 $4.24 Million
Q1 2021 May 14, 2021	SELL	$126.83 - $175.69 $2.37 Million - $3.29 Million	-18,700 Reduced 83.11%	3,800 $537,000
Q3 2020 Nov 13, 2020	BUY	$121.19 - $165.49 $2.46 Million - $3.36 Million	20,300 Added 922.73%	22,500 $3.28 Million
Q2 2020 Aug 14, 2020	SELL	$104.21 - $156.44 $1.34 Million - $2.02 Million	-12,900 Reduced 85.43%	2,200 $326,000
Q4 2019 Feb 13, 2020	SELL	$74.51 - $124.23 $558,825 - $931,725	-7,500 Reduced 33.19%	15,100 $1.74 Million
Q1 2019 May 15, 2019	BUY	$72.76 - $93.45 $1.64 Million - $2.11 Million	22,600 New	22,600 $2.11 Million

Others Institutions Holding ALNY

# of Institutions

643

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

Capital World Investors Los Angeles, CA

16.5M
Shares

$4.05 Billion
0.73% of portfolio
Vanguard Group Inc Valley Forge, PA

12.6M
Shares

$3.1 Billion
0.06% of portfolio
Black Rock Inc. New York, NY

9.55M
Shares

$2.34 Billion
0.05% of portfolio
Capital Research Global Investors Los Angeles, CA

5.24M
Shares

$1.29 Billion
0.31% of portfolio
Wellington Management Group LLP Boston, MA

4.95M
Shares

$1.22 Billion
0.24% of portfolio

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30.2B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.

Account